What does CUSIP 890260854 represent in this 13F holders report?

CUSIP 890260854 is the security identifier for TNXP - Tonix Pharmaceuticals Holding Corp. - Common Stock used to aggregate holder disclosures.

How many institutions held TNXP - Tonix Pharmaceuticals Holding Corp. - Common Stock in Q3 2024?

No institutional holders were reported for TNXP - Tonix Pharmaceuticals Holding Corp. - Common Stock in Q3 2024; review adjacent reporting periods for trend context.

Tonix Pharmaceuticals Holding Corp. - Common Stock (TNXP)

CUSIP: 890260854

Q3 2024 13F Holders as of 30 Sep 2024

Type / Class: Equity / Common Stock
Shares outstanding: 186,616,143
Total 13F shares: 0
Share change: -28,155
Total reported value: $0
Number of holders: 0
Value change: -$19,636
Number of sells: 2

Quarterly Holders Quick Answers

What is CUSIP 890260854?
CUSIP 890260854 identifies TNXP - Tonix Pharmaceuticals Holding Corp. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Previous quarter: Q2 2024

Recent filing periods for CUSIP 890260854:

Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023

Tonix Pharmaceuticals Holding Corp. - Common Stock (TNXP)

Q3 2024 13F Holders as of 30 Sep 2024

Quarterly Holders Quick Answers

Related Filing Research

Explore More Reporting Periods

There are no holders of TNXP - Tonix Pharmaceuticals Holding Corp. - Common Stock as of Q3 2024.